Notes - Segment Information

Astellas Pharma Inc. - Filing #7711337

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
Notes - Segment information
Segment information
Revenue
Revenue
1,306,348,000,000 JPY
1,300,316,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
-1,627,000,000 JPY
-2,419,000,000 JPY
Profit (loss) before tax
248,967,000,000 JPY
218,113,000,000 JPY
Assets
1,897,648,000,000 JPY
1,858,205,000,000 JPY
Investments accounted for using equity method
3,653,000,000 JPY
3,138,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.